NCT07751159
Radiation Therapy Approaches for People With Prostate Cancer
Recruiting · Phase 2 · Memorial Sloan Kettering Cancer Center · registry updated 2026-08-12
Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.
The purpose of the study is to explore the best ways of giving radiation therapy to balance cancer control and treatment side effects.
Inclusion
- Non-metastatic prostate cancer.
- Classified as unfavorable intermediate-, high-, or very high-risk prostate cancer according to NCCN risk stratification guidelines. (Note: cT3a or T3b by MRI or PSMA PET allowed)
- Considered by the treating radiation oncologist as a suitable candidate for both HDR brachytherapy boost and SBRT